Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Stehman-Breen
Anemia Treatment With Q2W Darbepoetin Alfa in Patients With Chronic Kidney Disease Naïve to Erythropoiesis-Stimulating Agents
Current Medical Research and Opinion
Medicine
Related publications
Managing Chemotherapy Induced Anemia With Darbepoetin Alfa and Other Erythropoiesis Stimulating Agents: A Nurse's Perspective
Nursing: Research and Reviews
Effects of Anemia Correction by Erythropoiesis-Stimulating Agents on Cardiovascular Function in Non-Dialysis Patients With Chronic Kidney Disease
International Heart Journal
Medicine
Cardiovascular Medicine
Cardiology
Erythropoiesis-Stimulating Agents Increase the Risk of Acute Stroke in Patients With Chronic Kidney Disease
Kidney International
Nephrology
PCN34 Cost Analysis of Anemia Treatment With Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Beneficial Effect of High Dose Darbepoetin-Alfa in Peritoneal Dialysis Patients With Renal Anemia
Nihon Toseki Igakkai Zasshi
Treatment Options for Anemia, Taking Risks Into Consideration: Erythropoiesis-Stimulating Agents Versus Transfusions
Oncologist
Cancer Research
Medicine
Oncology
Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update
Journal of Oncology Practice
Health Policy
Oncology
Potential Health Economic Impact of Intravenous Iron Supplementation to Erythropoiesis-Stimulating Agent Treatment in Patients With Cancer- Or Chemotherapy-Induced Anemia
Oncology
Medicine
Cancer Research
Oncology
Novel Erythropoiesis Stimulating Protein (NESP) for the Treatment of Anaemia of Chronic Disease Associated With Cancer
British Journal of Cancer
Cancer Research
Oncology
